Personalis promoted Richard Chen to President while he continues to serve as Chief Medical Officer. In the President role, Chen will oversee integration across R&D, biopharma services, reimbursement, quality systems, and medical affairs. Chief Executive Officer Chris Hall said the change is intended to align R&D with operational execution as the company expands its minimal residual disease testing efforts.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Personalis Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603171600BIZWIRE_USPR_____20260317_BW575420) on March 17, 2026, and is solely responsible for the information contained therein.
Comments